BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7000081)

  • 1. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance.
    Singer FR; Fredericks RS; Minkin C
    Arthritis Rheum; 1980 Oct; 23(10):1148-54. PubMed ID: 7000081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment.
    Woodhouse NJ; Mohamedally SM; Saed-Nejad F; Martin TJ
    Br Med J; 1977 Oct; 2(6092):927-9. PubMed ID: 410477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R; Dambacher MA; Perrenoud A; Simon C; Fischer JA
    Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of salmon calcitonin in Paget's disease of bone.
    Singer FR
    Calcif Tissue Int; 1991; 49 Suppl 2():S7-8. PubMed ID: 1933617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S; Rosenberg E; Haddad JG
    Lancet; 1974 Dec; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG; Caldwell JG
    J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of antibody formation after long-term salmon calcitonin therapy.
    Hosking DJ; Denton LB; Cadge B; Martin TJ
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):243-52. PubMed ID: 572275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F; Ringe JD; Kruse HP
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A; Flores A; DeRose J; Wallach S
    J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A
    Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
    [No Abstract]   [Full Text] [Related]  

  • 13. Formation of antibodies to synthetic human calcitonin during treatment of Paget's disease.
    Dietrich FM; Fischer JA; Bijvoet OL
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):468-76. PubMed ID: 517048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neutralizing antibodies against salmon calcitonin. The cause of a treatment failure in Paget's disease].
    Grauer A; Frank-Raue K; Schroth J; Raue F; Ziegler R
    Dtsch Med Wochenschr; 1994 Apr; 119(14):507-10. PubMed ID: 8156882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease.
    Levy F; Muff R; Dotti-Sigrist S; Dambacher MA; Fischer JA
    J Clin Endocrinol Metab; 1988 Sep; 67(3):541-5. PubMed ID: 3410939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE
    Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
    Reginster JY; Gennari C; Mautalen C; Deroisy R; Denis D; Lecart MP; Vandalem JL; Collette J; Franchimont P
    Scand J Rheumatol; 1990; 19(1):83-6. PubMed ID: 2309107
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of antibodies and clinical resistance to salmon calcitonin.
    Singer FR; Aldred JP; Neer RM; Krane SM; Potts JT; Bloch KJ
    J Clin Invest; 1972 Sep; 51(9):2331-8. PubMed ID: 4674133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.
    Grauer A; Raue F; Schneider HG; Frank-Raue K; Ziegler R
    J Bone Miner Res; 1990 Apr; 5(4):387-91. PubMed ID: 2343778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human calcitonin treatment of Paget's disease of bone.
    Singer FR
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.